PDF(Pubmed)
Abstract：
UNASSIGNED: To evaluate the surgical visual outcomes of three-piece rigid scleral fixated intraocular lens (SFIOL) implantation in subjects with deficient posterior capsule following complications of cataract extraction.
UNASSIGNED: Retrospective 4-year cohort study.
UNASSIGNED: Data from 174 eyes that underwent SFIOL combined with pars plana vitrectomy (PPV) between January 2018 and March 2022 and follow-up exams were included.
UNASSIGNED: Demographic characteristics including primary indications for surgery, history of trauma, laterality, baseline and best-corrected visual acuity (BCVA), refraction as spherical equivalent (SE), intraocular pressure (IOP), duration of follow-up, and complications were analyzed.
UNASSIGNED: The mean preoperative BCVA was 1.38 ± 0.46 logarithm of the minimum angle of resolution (logMAR), which improved significantly to 0.37 ± 0.22 logMAR. The baseline refractive status measured in spherical equivalent (SE) was 4.1 ± 6.2 Diopters (D), and the postoperative status was -0.4 ± 0.97 D. Early postoperative complications included hypotony (n = 1; 0.57%, vitreous hemorrhage (n = 3; 1.72%), elevated IOP (n = 8; 4.59%), mild dilated pupil (n = 1; 0.57%) and corneal edema (n = 16; 9.19%). Late complications included in this study were retinal detachment (n = 1; 0.57%), cystoid macular edema (CME) (n = 1; 0.57%), primary glaucoma (n = 1; 0.57%), secondary glaucoma (n = 13; 7.47%), zonular dehiscence (n = 3; 1.72%), retinal pigment epithelium (RPE) changes (n = 3; 1.72%), choroidal coloboma (n = 2; 1.14%), posterior dislocation of posterior chamber IOL (PCIOL) (n = 1; 0.57%), corneal decompensation (n = 1; 0.57%), retinal hemorrhage (n = 1; 0.57%), macular hole (n = 1; 0.57%), chronic uveitis (n = 1; 0.57%), mild non-proliferative diabetic retinopathy (NPDR) (n = 3; 1.72%), and mild NPDR with diabetic macular edema (DME) (n = 1; 0.57%).
UNASSIGNED: Integrating IOL implantation with vitrectomy various posterior segment complications were resolved in the same setting without attempting a second surgery.
UNASSIGNED: Retrospective 4-year cohort study.
UNASSIGNED: Data from 174 eyes that underwent SFIOL combined with pars plana vitrectomy (PPV) between January 2018 and March 2022 and follow-up exams were included.
UNASSIGNED: Demographic characteristics including primary indications for surgery, history of trauma, laterality, baseline and best-corrected visual acuity (BCVA), refraction as spherical equivalent (SE), intraocular pressure (IOP), duration of follow-up, and complications were analyzed.
UNASSIGNED: The mean preoperative BCVA was 1.38 ± 0.46 logarithm of the minimum angle of resolution (logMAR), which improved significantly to 0.37 ± 0.22 logMAR. The baseline refractive status measured in spherical equivalent (SE) was 4.1 ± 6.2 Diopters (D), and the postoperative status was -0.4 ± 0.97 D. Early postoperative complications included hypotony (n = 1; 0.57%, vitreous hemorrhage (n = 3; 1.72%), elevated IOP (n = 8; 4.59%), mild dilated pupil (n = 1; 0.57%) and corneal edema (n = 16; 9.19%). Late complications included in this study were retinal detachment (n = 1; 0.57%), cystoid macular edema (CME) (n = 1; 0.57%), primary glaucoma (n = 1; 0.57%), secondary glaucoma (n = 13; 7.47%), zonular dehiscence (n = 3; 1.72%), retinal pigment epithelium (RPE) changes (n = 3; 1.72%), choroidal coloboma (n = 2; 1.14%), posterior dislocation of posterior chamber IOL (PCIOL) (n = 1; 0.57%), corneal decompensation (n = 1; 0.57%), retinal hemorrhage (n = 1; 0.57%), macular hole (n = 1; 0.57%), chronic uveitis (n = 1; 0.57%), mild non-proliferative diabetic retinopathy (NPDR) (n = 3; 1.72%), and mild NPDR with diabetic macular edema (DME) (n = 1; 0.57%).
UNASSIGNED: Integrating IOL implantation with vitrectomy various posterior segment complications were resolved in the same setting without attempting a second surgery.
摘要：
■评估在白内障摘除并发症后后囊不足的受试者中，三片刚性巩膜固定人工晶状体（SFIOL）植入的手术视觉效果。
■回顾性4年队列研究。
■纳入了在2018年1月至2022年3月期间接受SFIOL联合平坦部玻璃体切除术（PPV）的174只眼的数据，并进行了随访检查。
■人口统计学特征，包括手术的主要适应症，外伤史,偏侧性,基线和最佳矫正视力（BCVA），折射为等效球面(SE)，眼内压（IOP），随访时间，并对并发症进行分析。
■术前平均BCVA为最小分辨角（logMAR）的1.38±0.46对数，显著提高至0.37±0.22logMAR。以等效球面（SE）测量的基线屈光状态为4.1±6.2屈光度（D），术后状态为-0.4±0.97D。术后早期并发症包括低眼压（n=1；0.57％，玻璃体出血（n=3；1.72%），IOP升高（n=8；4.59%），轻度瞳孔扩张（n=1；0.57％）和角膜水肿（n=16；9.19％）。本研究的晚期并发症包括视网膜脱离（n=1；0.57％），黄斑囊样水肿（CME）（n=1；0.57％），原发性青光眼（n=1；0.57％），继发性青光眼（n=13；7.47%），带状裂开（n=3；1.72%），视网膜色素上皮（RPE）变化（n=3；1.72％），脉络膜缺损（n=2；1.14%），后房型人工晶状体（PCIOL）后脱位（n=1；0.57％），角膜代偿失调（n=1；0.57％），视网膜出血（n=1;0.57％），黄斑裂孔（n=1；0.57%），慢性葡萄膜炎（n=1；0.57％），轻度非增生性糖尿病视网膜病变（NPDR）（n=3;1.72％），和轻度NPDR伴糖尿病性黄斑水肿（DME）（n=1；0.57％）。
■将人工晶体植入术与玻璃体切除术相结合，在相同的环境中，各种后段并发症得以解决，而无需尝试第二次手术。
■回顾性4年队列研究。
■纳入了在2018年1月至2022年3月期间接受SFIOL联合平坦部玻璃体切除术（PPV）的174只眼的数据，并进行了随访检查。
■人口统计学特征，包括手术的主要适应症，外伤史,偏侧性,基线和最佳矫正视力（BCVA），折射为等效球面(SE)，眼内压（IOP），随访时间，并对并发症进行分析。
■术前平均BCVA为最小分辨角（logMAR）的1.38±0.46对数，显著提高至0.37±0.22logMAR。以等效球面（SE）测量的基线屈光状态为4.1±6.2屈光度（D），术后状态为-0.4±0.97D。术后早期并发症包括低眼压（n=1；0.57％，玻璃体出血（n=3；1.72%），IOP升高（n=8；4.59%），轻度瞳孔扩张（n=1；0.57％）和角膜水肿（n=16；9.19％）。本研究的晚期并发症包括视网膜脱离（n=1；0.57％），黄斑囊样水肿（CME）（n=1；0.57％），原发性青光眼（n=1；0.57％），继发性青光眼（n=13；7.47%），带状裂开（n=3；1.72%），视网膜色素上皮（RPE）变化（n=3；1.72％），脉络膜缺损（n=2；1.14%），后房型人工晶状体（PCIOL）后脱位（n=1；0.57％），角膜代偿失调（n=1；0.57％），视网膜出血（n=1;0.57％），黄斑裂孔（n=1；0.57%），慢性葡萄膜炎（n=1；0.57％），轻度非增生性糖尿病视网膜病变（NPDR）（n=3;1.72％），和轻度NPDR伴糖尿病性黄斑水肿（DME）（n=1；0.57％）。
■将人工晶体植入术与玻璃体切除术相结合，在相同的环境中，各种后段并发症得以解决，而无需尝试第二次手术。
